SEC Form 4 · accession 0001547522-16-000208
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan E Rothschild
Director · 10% Owner
Period of report
Jan 29, 2016
Accepted (ET)
Feb 1, 2016 · 5:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.10 per shareF1 | Jan 29, 2016 | P | 4,761 | $5.25 | A | 505,397 | D | |
| Common Stock, par value $0.10 per shareF2 | Jan 29, 2016 | P | 4,761 | $5.25 | A | 510,158 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired by Arterio Inc., a corporation owned solely by Mr. Rothschild.
- F2This figure includes 226,416 shares of common stock held by Arterio Inc., a corporation owned solely by Mr. Rothschild.